Join to View Full Profile
620 Northwestern DrSte 1Storm Lake, IA 50588
Phone+1 712-732-5030
Fax+1 712-732-1519
Dr. Archer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Practice Family Medicine and Occupational Medicine, provide disability physicals and IME's
Education & Training
Medical College of Wisconsin Affiliated Hospitals/Wheaton Franciscan Healthcare-All SaintsResidency, Family Medicine, 1983 - 1986- Medical College of WisconsinClass of 1983
Certifications & Licensure
IA State Medical License 1986 - 2027
WI State Medical License 1984 - 1987
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 9 citationsPlasma metabolomics analysis in sickle cell disease patients with albuminuria – an exploratory studyLaila Elsherif, Wimal Pathmasiri, Susan McRitchie, David R. Archer, Kenneth I. Ataga
British Journal of Haematology. 2019-05-01 - 14 citationsRenal protection by atorvastatin in a murine model of sickle cell nephropathyRima S. Zahr, Prasanthi Chappa, Hong Yin, Lou Ann S. Brown, Kenneth I. Ataga
British Journal of Haematology. 2018-04-01 - 10 citationsImpaired Collateral Vessel Formation in Sickle Cell Disease.Derick Okwan-Duodu, Laura Hansen, Giji Joseph, Alicia N. Lyle, Daiana Weiss
Arteriosclerosis, Thrombosis, and Vascular Biology. 2018-01-01
Grant Support
- Small Molecule Therapeutics for Sickle Cell AnemiaEMORY UNIVERSITY2023–2026
- Small Molecule Therapeutics for Sickle Cell AnemiaEMORY UNIVERSITY2023–2025
- Endothelial Dysfunction In The Pathogenesis Of Sickle Cell NephropathyNational Heart, Lung, And Blood Institute2012
- The Pathogenesis Of Sickle Cell NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Allogeneic Chimerism In Murine Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
